Insmed, Inc. (INSM)
163.46
-0.26
(-0.16%)
USD |
NASDAQ |
Jan 14, 16:00
163.00
-0.46
(-0.28%)
After-Hours: 20:00
Insmed EPS Diluted (Quarterly): -1.747 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Biogen, Inc. | 3.171 |
| Pfizer Inc. | 0.6197 |
| Merck & Co., Inc. | 2.316 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -370.02M |
| Revenue (Quarterly) | 142.34M |
| Total Expenses (Quarterly) | 512.36M |
| Enterprise Value | 33.93B |
| Gross Profit Margin (Quarterly) | 78.29% |
| Profit Margin (Quarterly) | -260.0% |
| Earnings Yield | -3.78% |
| Normalized Earnings Yield | -3.430 |